Portal de Periódicos da CAPES

Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies

2013; Wiley; Volume: 48; Issue: 5 Linguagem: Inglês

10.1002/mus.23851

1097-4598

Erdem Tüzün, Demet Kınay, Yael Hacohen, Fikret Aysal, Angela Vincent,

Myasthenia Gravis and Thymoma

Muscle & NerveVolume 48, Issue 5 p. 836-837 Letter to the Editor Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies Erdem Tüzün MD, Erdem Tüzün MD Department of Neuroscience, Institute of Experimental Medicine and Research, Istanbul University, Istanbul, TurkeySearch for more papers by this authorDemet Kinay MD, Demet Kinay MD Bakırköy State Hospital for Research and Training in Neurology, Neurosurgery, and Psychiatry, Istanbul, TurkeySearch for more papers by this authorYael Hacohen MD, Yael Hacohen MD Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford University, Oxford, United KingdomSearch for more papers by this authorFikret Aysal MD, Fikret Aysal MD Bakırköy State Hospital for Research and Training in Neurology, Neurosurgery, and Psychiatry, Istanbul, TurkeySearch for more papers by this authorAngela Vincent MBBS, FRCPath, Angela Vincent MBBS, FRCPath Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford University, Oxford, United KingdomSearch for more papers by this author Erdem Tüzün MD, Erdem Tüzün MD Department of Neuroscience, Institute of Experimental Medicine and Research, Istanbul University, Istanbul, TurkeySearch for more papers by this authorDemet Kinay MD, Demet Kinay MD Bakırköy State Hospital for Research and Training in Neurology, Neurosurgery, and Psychiatry, Istanbul, TurkeySearch for more papers by this authorYael Hacohen MD, Yael Hacohen MD Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford University, Oxford, United KingdomSearch for more papers by this authorFikret Aysal MD, Fikret Aysal MD Bakırköy State Hospital for Research and Training in Neurology, Neurosurgery, and Psychiatry, Istanbul, TurkeySearch for more papers by this authorAngela Vincent MBBS, FRCPath, Angela Vincent MBBS, FRCPath Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford University, Oxford, United KingdomSearch for more papers by this author First published: 20 March 2013 https://doi.org/10.1002/mus.23851Citations: 13Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012; 366: 2294–2304. 10.1056/NEJMra1114525 CASPubMedWeb of Science®Google Scholar 2 Rosen BA. Guillain-Barré syndrome. Pediatr Rev 2012; 33: 164–170. 10.1542/pir.33-4-164 PubMedGoogle Scholar 3 Antoine JC, Mosnier JF, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999; 67: 7–14. 10.1136/jnnp.67.1.7 CASPubMedWeb of Science®Google Scholar 4 Lagrange E, Veran O, Besson G. Pure motor relapsing Guillain-Barré syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer. Eur J Neurol 2007; 14: e7. 10.1111/j.1468-1331.2007.01990.x CASPubMedWeb of Science®Google Scholar 5 Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135–1140. 10.1136/jnnp.2003.034447 CASPubMedWeb of Science®Google Scholar 6 Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734–2748. 10.1093/brain/awq213 PubMedWeb of Science®Google Scholar 7 Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012; 72: 241–255. 10.1002/ana.23577 PubMedWeb of Science®Google Scholar 8 Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997; 41: 238–246. 10.1002/ana.410410215 CASPubMedWeb of Science®Google Scholar 9 Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011; 69: 303–311. 10.1002/ana.22297 CASPubMedWeb of Science®Google Scholar 10 Tüzün E, Kürtüncü M, Lang B, Icöz S, Akman-Demir G, Eraksoy M, et al. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 2010; 17: 1304–1307. 10.1111/j.1468-1331.2010.02993.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume48, Issue5November 2013Pages 836-837 ReferencesRelatedInformation